SN-38 liposome
Term · Oncology and biomedicine · MLC-T-ONC-007831
A form of the anticancer drug irinotecan that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than irinotecan alone. SN-38 liposome is being studied in the treatment of advanced colorectal cancer and other types of cancer. SN-38 liposome blocks the ability of cells to divide and grow. It may stop the growth of tumor cells. It is a type of topoisomerase inhibitor and a type of irinotecan (CPT-11) derivative. Also called liposomal SN-38.
| Identifier | MLC-T-ONC-007831 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | liposomal SN-38 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007831",
"term": "SN-38 liposome",
"field": "Oncology and biomedicine",
"definition": "A form of the anticancer drug irinotecan that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than irinotecan alone. SN-38 liposome is being studied in the treatment of advanced colorectal cancer and other types of cancer. SN-38 liposome blocks the ability of cells to divide and grow. It may stop the growth of tumor cells. It is a type of topoisomerase inhibitor and a type of irinotecan (CPT-11) derivative. Also called liposomal SN-38.",
"synonyms": [
"liposomal SN-38"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/sn-38-liposome/"
}
Record 15,107 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.